June 17, 2009 - First ZOLL Integrated Automated Compression-Defibrillation System Purchased INVESTOR CONTACT: A. Ernest WhitonChief Financial OfficerZOLL Medical Corporation+1 (978) 421-9655 MEDIA CONTACT: Diane EganZOLL Medical Corporation+1 (978) firstname.lastname@example.org DUTCH AMBULANCE SERVICE FIRST TO PURCHASE ZOLL INTEGRATED AUTOMATED COMPRESSION-DEFIBRILLATION SYSTEM Now Able to Defibrillate a Heart Without Interruptions in Resuscitation June 17, 2009—CHELMSFORD, Mass.—ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that the ambulance service, RAV Gooi en Vechtstreek in Hilversum, The Netherlands, is the first EMS organization to equip its ambulances with a revolutionary new system that allows rescuers to defibrillate a heart without the need to stop chest compressions. The real-time integrated operation of the new AutoPulse® Plus and the E Series® coordinates the ability to provide consistent, uninterrupted chest compressions with timed shock delivery. Integrating these two therapeutic interventions into a seamless rescue effort has long been viewed as critical to advancing resuscitation care. Stopping chest compressions during defibrillation results in a rapid fall in coronary perfusion pressure. Both the AutoPulse Plus and the E Series have the CE Mark; however, the new AutoPulse Plus does not yet have 510(k) FDA clearance in the U.S. “Our evaluations of this integrated system demonstrated that we are able to maximize the likelihood of shock success and minimize no flow time,” said Frank Berg, Manager of Operations of RAV Gooi en Vechtstreek. “This technological solution could be significant to improving outcomes from sudden cardiac arrest.” “Avoiding interruptions in defibrillation is among the highest priorities in resuscitation care. With timed shock delivery, which is the ability to deliver the treatment at the optimum time during the compression cycle without stopping CPR, another important step forward in improving survival from sudden cardiac arrest has been taken,” said Jonathan A. Rennert, President of ZOLL. Like the current AutoPulse, the new AutoPulse Plus helps provide the consistent, uninterrupted chest compressions called for by the European Resuscitation Council Guidelines. It is an automated, portable device with an easy-to-use, load-distributing LifeBand® that squeezes the entire chest, improving blood flow to the heart and brain during sudden cardiac arrest (SCA). The AutoPulse offers a significant advantage over manual CPR because it moves more blood, more consistently, than is possible with human hands. AutoPulse delivers high-quality, uninterrupted chest compressions to maintain myocardial and cerebral perfusion. It offers the benefit of freeing up rescuers to focus on other life-saving interventions, and keeps them safer by eliminating the need to conduct CPR while unrestrained in the back of a moving ambulance. Over 4,000 AutoPulse units have been deployed in hospitals and emergency services worldwide. The unmatched ruggedness of the E Series was designed by EMS professionals to meet the specific demands and extreme conditions that professional rescuers face every day. The E Series features ZOLL’s unique See-Thru CPR® to filter out CPR artifact, allowing rescuers to see organized rhythms without interrupting chest compressions. Like all other ZOLL defibrillators, the E Series also provides Real CPR Help®, which improves CPR quality by providing real-time feedback on the rate and depth of chest compressions. The E Series also now offers a new, easy-to-use, wireless 12-lead transmission feature. About Sudden Cardiac Arrest SCA, an abrupt disruption of the heart’s function, which causes a lack of blood flow to vital organs, claims more than 325,000 lives each year in the U.S. It is the leading cause of unexpected death in the world and strikes without warning. Currently, only about 5 percent of victims survive; 95 percent will die from SCA. About ZOLL Medical Corporation ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation, temperature management, and fluid resuscitation, ZOLL provides a comprehensive set of technologies, including Real CPR Help® and See-Thru CPR®, which help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information. ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia. During 2008 ZOLL marked the 25th anniversary of the company’s resuscitation product development. For more information, visit www.zoll.com. Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Quarterly Report on Form 10-Q filed with the SEC on May 8, 2009. You should not place undue reliance on the forward-looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements. Copyright © 2009 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL, AutoPulse, E Series, LifeBand, Real CPR Help, and See-Thru CPR are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.